Nova Patents
PL3038601T3

Combination formulation of two antiviral compounds

Abstract

This record has no abstract on file.

Term

7.4 yearsto projected expiry

Projected expiry 30 January 2034, counted from filing; an application has no term until it is granted.

  1. Priority and filed
  2. Published
  3. Today
  4. Projected expiry

54 members in 21 offices

This recordMember, by publication date11 more offices are in the list below

Members54

Family members, oldest first
DocumentOfficeKind
CA2921160A1CanadaA1
US2015064253A1United States of AmericaA1
WO2015030853A1World Intellectual Property Organization (WIPO)A1
UY35300AUruguayA
TW201511756ATaiwan Province of ChinaA
AR095133A1ArgentinaA1
AU2014311827A1AustraliaA1
SG11201600919UASingaporeA
CN105517540AChinaA
IL243988A0IsraelA0
IL243988D0IsraelD0
KR20160047522ARepublic of KoreaA
MX2016002185AMexicoA
EP3038601A1European Patent Office (EPO)A1
JP2016529293AJapanA
EA201690473A1Eurasian Patent Organization (EAPO)A1
US2017095499A1United States of AmericaA1
HK1220392AHong Kong, ChinaA
HK1220392A1Hong Kong, ChinaA1
NZ716840ANew ZealandA
US9757406B2United States of AmericaB2
AU2014311827B2AustraliaB2
HK1225626AHong Kong, ChinaA
HK1225626A1Hong Kong, ChinaA1
JP2017222718AJapanA
AU2017276223A1AustraliaA1
US2018021362A1United States of AmericaA1
TWI626048BTaiwan Province of ChinaB
JP6360607B2JapanB2
US10086011B2United States of AmericaB2
US2019240246A1United States of AmericaA1
CN105517540BChinaB
AU2017276223B2AustraliaB2
AU2019264624A1AustraliaA1
EP3038601B1European Patent Office (EPO)B1
EP3650014A1European Patent Office (EPO)A1
PT3038601TPortugalT
SI3038601T1SloveniaT1
PL3038601T3This recordPolandT3
ES2792503T3SpainT3
US2021000854A1United States of AmericaA1
KR102239196B1Republic of KoreaB1
CA2921160CCanadaC
US11116783B2United States of AmericaB2
EP3650014B1European Patent Office (EPO)B1
AU2019264624B2AustraliaB2
PT3650014TPortugalT
PL3650014T3PolandT3
SI3650014T1SloveniaT1
US2022072021A1United States of AmericaA1
ES2900570T3SpainT3
EP4005560A1European Patent Office (EPO)A1
US11707479B2United States of AmericaB2
EP4005560B1European Patent Office (EPO)B1